Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Renovated PLG Limestone Asks $2.75 Million
In the Prospect Lefferts Gardens Historic District, this early 20th century row house was designed by prolific architect Benjamin Driesler and recently updated by a Brooklyn design-build firm. While the original architect gave the interior its moldings, wood floors, and

